P-335FOLFIRINOX versus Nab-paclitaxel plus gemcitabine in...

P-335FOLFIRINOX versus Nab-paclitaxel plus gemcitabine in the first-line chemotherapy for patients with advanced pancreatic ductal adenocarcinoma: a multivariate analysis of prognostic factors in a national cohort (Comunica-TTD working group)

Longo Muñoz, F, Castillo Trujillo, O, Serrano Domingo, J, Martín Huertas, R, Corral de la Fuente, E, San Juan, A, Portela, J, Cano, J, Reguera Puertas, P, Rodriguez Garrote, M, Izquierdo Manuel, M, Ji
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz155.334
Date:
July, 2019
File:
PDF, 98 KB
2019
Conversion to is in progress
Conversion to is failed